+

- .

.-. ..

2013

25%
12-15%

30%
30%

Speroff L. 2006

,
/

,


(
,

15-20%

( ),

2-3% ,
,

 () ()

-
,2009

,
.
, ,
. 624,
2008






35

Edward E. Wallach, 2005




50%

1970
1980
1990
2000

8
16
28

70-80
60-70
50-60

36

50-60


/, 50-60 ,
.

4-6 /

40-50%!!!

Speroff L. 2006

/
1

% /

12%

24%

26%

32%

26%

53%

40-45%
Speroff L. 2006


,
, , ..

G2

G1
G6

TRAIT

G3

G10
G5

G9

G4

G8

,

,


( ,)

(
)

,
, ,





(
, )

,
...


, , ,

Evidence-based guidelines for the investigation and medicaltreatment of recurrent miscarriage.

E. Jauniaux, R. G.Farquharson, O. B.Christiansen, N Exalto 2006

 ,


NK-


,

Multifactorial Etiology of Recurrent Miscarriage and Its Scientific and Clinical Implications

Gynecol Obstet Invest 2008;66:257267

Ole B. Christiansen, Rudi Steffensen, Henriette S. Nielsen,Kim Varming 2008

 :

3 (67%), (2%).
50%
uterus didelphys 40%
30-40%
65%

Speroff L. 2006

( )

,
( )

( )

Speroff L. 2006


,

Uterus didelphys
( 50% ),
, .


% .


80%. ( ) .

Speroff L. 2006


2008 .:
Am J Obstet Gynecol. 2008 Apr;198(4):357-66.
Fibroids and reproductive outcomes: a systematic literature review from conception to
delivery.
Klatsky PC, Tran ND, Caughey AB, Fujimoto VY.

, -0.5; 95% 0.3-0.8,
;

: 36.9% 41.1%;
/ 20.4%
12.9%.

(
, )

[Sunkara S. Khairy M., 2010];

,
,

 ,
, IVF: . 2010
The effect of intramural fibroids without uterine
cavity involvement on the outcome of IVF
treatment: a systematic review and meta-analysis
Sesh Kamal Sunkara, Mohammed Khairy, Tarek
El-Toukhy, Yacoub Khalaf and Arri
Coomarasamy
Human Reproduction 2010 25(2):418-429;

:
,


.

 ,
?

?
Ravina, JH, Vigneron, NC, Aymard, A, et al. Pregnancy after embolization of uterine myoma: report of 12
cases. Fertil Steril 2000; 73:1241.
McLucas, B, Goodwin, S, Adler, L, et al. Pregnancy following uterine fibroid embolization. Int J Gynaecol Obstet
2001; 74:1.
Goldberg, J, Pereira, L, Berghella, V. Pregnancy after uterine artery embolization. Obstet Gynecol 2002; 100:869.
Goldberg J, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization
versus laparoscopic myomectomy. Am J Obstet Gynecol 2004; 191:18.
Pron, G, Mocarski, E, Bennett, J, et al. Pregnancy after uterine artery embolization for leiomyomata: the
ontario multicenter trial. Obstet Gynecol 2005; 105:67.
Carpenter, TT, Walker, WJ. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series
of 26 completed pregnancies. BJOG 2005; 112:321.
Goodwin, SC, Bradley, LD, Lipman, JC, et al. Uterine artery embolization versus myomectomy: a multicenter
comparative study. Fertil Steril 2006; 85:14.
Walker, WJ, McDowell, SJ. Pregnancy after uterine artery embolization for leiomyomata: a series of 56
completed pregnancies. Am J Obstet Gynecol 2006; 195:1266.
Mara, M, Maskova, J, Fucikova, Z, et al. Midterm clinical and first reproductive results of a randomized
controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008;
31:73.
Pinto Pabon, I, Magret, JP, Unzurrunzaga, EA, et al. Pregnancy after uterine fibroid embolization: follow-up of
100 patients embolized using tris-acryl gelatin microspheres. Fertil Steril 2008; 90:2356.
Homer, H, Saridogan, E. Uterine artery embolization for fibroids is associated with an increased risk of
miscarriage. Fertil Steril 2009

,


Obstetric outcomes after treatment of fibroids by uterine artery embolization: a
systematic review
Shilpi Sud, Abha Maheshwari, Siladitya Bhattacharya Expert Review of Obstetrics &
Gynecology 2009, Vol. 4, No. 4, Pages 429-441
-

57.8% (137/237) 77.4%

(1759/2273) (p < 0.001).
/, ,
.

NB! , :
,

!!!

NB!


( ,
...)


/ 40-80%

50-90%
/ 7-23%

E. Jauniaux, R. G.Farquharson, O. B.Christiansen, N Exalto 2006, Speroff L.2006

,
.

http://www.fetalmedicine.com/fmf/online-education/05-cervical-assessment/

18

 -

/,

-
-

:
2,5

2,5

2,5
/ 40%

: ,
, ,
,
624, 2007
Cervical insufficiency. 2003 American College of Obstetricians and Gynecologists - Medical Specialty Society


75% / ,
30% /
3%
.
- 90% -
10% -
!!! /
,

The ESHRE Capri Workshop Group, 2008

4-8%.

The ESHRE Capri Workshop Group, 2008


(13,14,15,21,22)
( ,
)




-
-
-
,

-
-
-



,



( ),

( , /, ).

 .
. 24.
2 / ( 8-9
). .
8-9 ,
.
:

1 - 15,
2 15.

 : 45,XX,der(15;15)(q10;q10)

100%

: 46XY
7-8 .
.


2 5% (12%) ,


3-9 .
15%20%
-
90%
(
, )
D. Cohen, S. P. Berger 2009

D. Cohen, S. P. Berger 2009

 2006. ().

:
-
-
- 10
- ( 34)
- 3 10 .
- 34

- IgM IgG
, , , ,
12 ,
;
- , ,
, 12 .

Mala Kaul, Doruk Erkan, Lisa Sammaritano, 2007


75-85/,
5-10 / 2 /,
()
3.0-4.0
34 .


D.Cohen, S.Berger, BMJ, V340, 2010,

Diagnosis and management of the antiphospholipid syndrome

- Rheumatology 2010 (334) +

,
( % )
A. Mark, M. Cheung, Rheumatology 2010

P.Ziakas, M. Pavlou, Obstet Gynecol. 2010 Jun;115

70-80%
( 2007.
54%)
(
, , ,
),
(,
)

!!!
!!! ()


,


,

G1691A

2-15%

3-8

() G20210

2-3 %

MTHFR

11 %

2,5-4

0,02 %

25-50

0,2-0,3 %

10-15

0,1-0,2 %

5-15%

VIII

se Rasmussen1, Pernille Ravn 2004



: ..
:
- G20210 ()
- activated protrombine C resistance
-
- ,S,

,

,


http://hubpages.com/hub/What-Is-Thrombophilia

LA



(NK, -)
-
,

-
(Mannan-binding lectine) ?
E. Jauniaux, R. G.Farquharson, O. B.Christiansen, N Exalto 2006

L.Speroff 2006

,
---,

!!!

R. G.Farquharson, O. B.Christiansen, N Exalto 2009

, ,
, -

.rck, J.Kalinka, J.Szekeres-Bartho, K.Wilch, , .., ..,

 .
???
Progestogen for treating threatened miscarriage
Cochrane Review by Wahabi HA, Fayed AA, Esmaeil SA, Al Zeidan RA

2011

.
,
. ,

.

- ,

-
- -



50- 10
,


.

2010

 :
( )
(

)
(, )




7 (< 10
ng/mL 31.8 nmol/L) -
.

,
< 30 ng/mL .

B.Sonntag, Clinical Endocrinology (2012) 77, 500507



100%


, .
.
.


: ..
2 , 1, 203-207
B.Sonntag, Clinical Endocrinology (2012) Glock 1995, K. Taniguchi 2004, Dal 2004, Hiroshi Tamura 2008


..


.
,
,
.

(
)

-

(, )
(, ,
, )

++

+++

+++

++/+++

/+

/+

++/+++

+/++

++/+++

++/+++

++

+++

++

+++

+++

+++

+++

/ 1,3

+++

/ 1,5

+++

++/+++

. 2006

 .

,

.

,
-
14 26
- 10 2 , 2-3 .

( 2/10+ 10 14 26 )


- -
:
,

.

- .

/,

().
- .
/ ().
E. Jauniaux, R. G.Farquharson, O. B.Christiansen, N Exalto 2006



30-34%,


5 - 15% ,
75%

- AZFa, AZFb,
AZFc
, R.H. Martin, 2008

 -
Tender and loving care

( )

P. L. Magee; A. K. Macleod; P. Tata; L. Regan 2003

: 2
,
1.


, , , , 17-, ,
7 , , , ,
, .
( , , ,
) + ,
.

( , )
, , ,
, , . .

: NK-, HLA,
,

C !